A Study in Participants With Anti-NMDAR Encephalitis and Anti-NMDAR Autoantibody-Associated Psychiatric Disease

Clinical trial NCT07093333 · RECRUITING

Trial details

NCT number: NCT07093333
Sponsor: Arialys Australia Pty Ltd
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Anti-N-methyl-D-aspartate Receptor (NMDAR) Encephalitis (ANRE)Anti-N-methyl-D-aspartate Receptor (NMDAR) Antibody-associated Psychiatric Disease Autoimmune Encephalitis

Start date: 2026-05-15
Primary completion: 2027-11-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.